This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2023
Title: Kishor Bhatia: Innovator in Cancer Treatment
Introduction
Kishor Bhatia is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of cancer treatment, particularly in addressing atypical teratoid/rhabdoid tumors. His innovative approach has the potential to impact the lives of many patients facing this challenging diagnosis.
Latest Patents
Kishor Bhatia holds a patent for a method of treating rhabdoid tumors. The patent, titled "Method for treating rhabdoid tumors," includes methods for treating atypical teratoid/rhabdoid tumors through the administration of HydroxyUreaMethyl Acylfulvene. This treatment specifically targets populations expressing the SMARCB1 gene, showcasing a tailored approach to cancer therapy. He has 1 patent to his name.
Career Highlights
Kishor Bhatia is currently associated with Lantern Pharma Inc., a company dedicated to advancing cancer treatment through innovative technologies. His work at Lantern Pharma reflects his commitment to improving patient outcomes and developing effective therapies for difficult-to-treat cancers.
Collaborations
Kishor has collaborated with talented individuals such as Aditya Jayant Kulkarni and Aditya Kulkarni. These collaborations highlight the importance of teamwork in the pursuit of groundbreaking medical advancements.
Conclusion
Kishor Bhatia's contributions to cancer treatment through his innovative patent demonstrate his dedication to improving healthcare. His work has the potential to change the landscape of treatment for rhabdoid tumors, offering hope to patients and their families.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile